Gilead Sciences Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Gilead Sciences Inc 公司

公司簡介

公司代碼GILD

公司名稱Gilead Sciences Inc

上市日期Jan 22, 1992

成立日期1987

CEOMr. Daniel P O'Day

員工數量17600

證券類型Ordinary Share

年結日Jan 22

公司地址333 Lakeside Dr

城市FOSTER CITY

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編94404-1147

電話16505743000

網址https://www.gilead.com/

公司代碼GILD

上市日期Jan 22, 1992

成立日期1987

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Ms. Johanna Mercier

Chief Commercial Officer

91.17K

+96.77%

Ms. Deborah H. (Deb) Telman

Executive Vice President - Corporate Affairs, General Counsel

32.43K

+61.66%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

24.54K

+10.39%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

10.23K

+29.16%

Ms. Kelly A. Kramer

Independent Director

1.33K

--

Mr. Harish Manwani

Independent Director

--

Dr. Jeffrey A. (Jeff) Bluestone, Ph.D.

Independent Director

--

Dr. Dietmar P. Berger, M.D., Ph.D.

Chief Medical Officer

--

Dr. Ted W. Love, M.D.

Director

--

Mr. Andrew D. (Andy) Dickinson

Chief Financial Officer

--

名稱

名稱/職務

職務

持股

持股變動

Ms. Johanna Mercier

Chief Commercial Officer

91.17K

+96.77%

Ms. Deborah H. (Deb) Telman

Executive Vice President - Corporate Affairs, General Counsel

32.43K

+61.66%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

24.54K

+10.39%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

10.23K

+29.16%

Ms. Kelly A. Kramer

Independent Director

1.33K

--

Mr. Harish Manwani

Independent Director

--

收入明細

單位: USD更新時間: 3月5日週三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

業務USD

名稱

營收

佔比

Biktarvy

13.42B

46.68%

Descovy

2.11B

7.34%

Genvoya

1.76B

6.12%

Sofosbuvir/Velpatasvir

1.59B

5.54%

Yescarta

1.57B

5.46%

Other

8.29B

28.83%

地區USD

名稱

營收

佔比

United States

19.50B

67.83%

Europe

4.34B

15.12%

Other Locations

2.90B

10.10%

業務

地區

業務USD

名稱

營收

佔比

Biktarvy

13.42B

46.68%

Descovy

2.11B

7.34%

Genvoya

1.76B

6.12%

Sofosbuvir/Velpatasvir

1.59B

5.54%

Yescarta

1.57B

5.46%

Other

8.29B

28.83%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

9.23%

BlackRock Institutional Trust Company, N.A.

5.97%

Capital World Investors

5.75%

State Street Global Advisors (US)

4.84%

Capital Research Global Investors

4.65%

Other

69.52%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

9.23%

BlackRock Institutional Trust Company, N.A.

5.97%

Capital World Investors

5.75%

State Street Global Advisors (US)

4.84%

Capital Research Global Investors

4.65%

Other

69.52%

股東類型

股東統計

佔比

Investment Advisor

42.83%

Investment Advisor/Hedge Fund

35.39%

Research Firm

3.20%

Pension Fund

3.00%

Sovereign Wealth Fund

1.73%

Bank and Trust

1.70%

Hedge Fund

1.59%

Holding Company

0.18%

Insurance Company

0.15%

Other

10.19%

機構持股

更新時間: 1月19日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

3200

1.12B

90.03%

+2.74M

2024Q4

3313

1.12B

90.13%

+4.62M

2024Q3

3207

1.10B

88.48%

-11.55M

2024Q2

3188

1.09B

88.24%

-14.36M

2024Q1

3196

1.09B

88.13%

-22.03M

2023Q4

3252

1.10B

88.75%

-8.78M

2023Q3

3190

1.09B

88.14%

-23.57M

2023Q2

3196

1.09B

88.02%

-11.21M

2023Q1

3195

1.08B

87.26%

-11.16M

2022Q4

3203

1.08B

86.64%

+1.09M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

114.96M

9.23%

+203.24K

+0.17%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

74.46M

5.97%

-1.75M

-2.30%

Dec 31, 2024

Capital World Investors

71.70M

5.75%

-4.84M

-6.32%

Dec 31, 2024

State Street Global Advisors (US)

60.38M

4.84%

+210.06K

+0.34%

Dec 31, 2024

Capital Research Global Investors

57.94M

4.65%

-3.85M

-6.23%

Dec 31, 2024

Wellington Management Company, LLP

35.65M

2.86%

+1.05M

+3.05%

Dec 31, 2024

Fidelity Management & Research Company LLC

34.64M

2.78%

+6.41M

+22.72%

Dec 31, 2024

Dodge & Cox

32.94M

2.64%

-98.02K

-0.29%

Dec 31, 2024

Geode Capital Management, L.L.C.

28.28M

2.27%

+749.04K

+2.71%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

25.27M

2.02%

+525.67K

+2.12%

Dec 31, 2024

持股ETF

更新時間: 13 小時前

機構名稱

佔比

VanEck Biotech ETF

11.91%

ProShares Ultra Nasdaq Biotechnology

8.91%

Invesco Nasdaq Biotechnology ETF

8.43%

iShares Biotechnology ETF

7.28%

Federated Hermes MDT Large Cap Value ETF

5.5%

Tema Oncology ETF

5.34%

Invesco Biotechnology & Genome ETF

5.22%

VanEck Morningstar Wide Moat Value ETF

4.48%

USCF Dividend Income Fund

4.34%

TBG Dividend Focus ETF

4.32%

VanEck Biotech ETF

佔比11.91%

ProShares Ultra Nasdaq Biotechnology

佔比8.91%

Invesco Nasdaq Biotechnology ETF

佔比8.43%

iShares Biotechnology ETF

佔比7.28%

Federated Hermes MDT Large Cap Value ETF

佔比5.5%

Tema Oncology ETF

佔比5.34%

Invesco Biotechnology & Genome ETF

佔比5.22%

VanEck Morningstar Wide Moat Value ETF

佔比4.48%

USCF Dividend Income Fund

佔比4.34%

TBG Dividend Focus ETF

佔比4.32%

分紅派息

近5年累計派現 18.48B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Nov 12, 2024

GILD.NB Final Cash Dividend of gross USD 0.77 paid on Dec 30, 2024 going ex on Dec 13, 2024

Dec 13, 2024

Dec 30, 2024

Dec 13, 2024

Aug 13, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Sep 27, 2024 going ex on Sep 13, 2024

Sep 13, 2024

Sep 27, 2024

Sep 13, 2024

Apr 26, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Jun 27, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jun 27, 2024

Jun 14, 2024

Feb 06, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Mar 28, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Mar 28, 2024

Mar 14, 2024

Nov 08, 2023

GILD.NB Final Cash Dividend of gross USD 0.75 paid on Dec 28, 2023 going ex on Dec 14, 2023

Dec 15, 2023

Dec 28, 2023

Dec 14, 2023

Aug 07, 2023

GILD.NB Interim Cash Dividend of gross USD 0.75 paid on Sep 28, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Sep 28, 2023

Sep 14, 2023

Apr 28, 2023

GILD.NB Interim Cash Dividend of gross USD 0.75 paid on Jun 29, 2023 going ex on Jun 14, 2023

Jun 15, 2023

Jun 29, 2023

Jun 14, 2023

Feb 02, 2023

GILD.NB Interim Cash Dividend of gross USD 0.75 paid on Mar 30, 2023 going ex on Mar 14, 2023

Mar 15, 2023

Mar 30, 2023

Mar 14, 2023

Oct 27, 2022

GILD.NB Final Cash Dividend of gross USD 0.73 paid on Dec 29, 2022 going ex on Dec 14, 2022

Dec 15, 2022

Dec 29, 2022

Dec 14, 2022

Aug 02, 2022

GILD.NB Interim Cash Dividend of gross USD 0.73 paid on Sep 29, 2022 going ex on Sep 14, 2022

Sep 15, 2022

Sep 29, 2022

Sep 14, 2022

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Gilead Sciences Inc

114.740USD

Gilead Sciences Inc

114.740

概覽

公司